Progesterone drives ER-positive and triple negative breast cancer cell proliferation through progesterone receptor membrane component 1

被引：0
|
作者：
Pedroza, D. A. [1 ]
Subramani, R. [1 ]
Galvez, A. [1 ]
Lakshmanaswamy, R. [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, El Paso Grad Sch Biomed Sci, El Paso, TX USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P5-05-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-05-12
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Progesterone receptor modulates ERα action in breast cancer
    Mohammed, Hisham
    Russell, I. Alasdair
    Stark, Rory
    Rueda, Oscar M.
    Hickey, Theresa E.
    Tarulli, Gerard A.
    Serandour, Aurelien A. A.
    Birrell, Stephen N.
    Bruna, Alejandra
    Saadi, Amel
    Menon, Suraj
    Hadfield, James
    Pugh, Michelle
    Raj, Ganesh V.
    Brown, Gordon D.
    D'Santos, Clive
    Robinson, Jessica L. L.
    Silva, Grace
    Launchbury, Rosalind
    Perou, Charles M.
    Stingl, John
    Caldas, Carlos
    Tilley, Wayne D.
    Carroll, Jason S.
    NATURE, 2015, 523 (7560) : 313 - +
  • [42] Expression of progesterone receptor membrane component 1 (PGRMC1) in tissues of breast cancer patients
    Wurster, I.
    Meisner, C.
    Seeger, H.
    Vogel, U.
    Schneck, H.
    Blassl, C.
    Schultz, S.
    Fehm, T.
    Neubauer, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 5
  • [43] May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?
    Zhang, Ying
    Ruan, Xiangyan
    Willibald, Marina
    Seeger, Harald
    Fehm, Tanja
    Neubauer, Hans
    Mueck, Alfred O.
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (01) : 58 - 60
  • [44] DEC1 directly interacts with estrogen receptor (ER) α to suppress proliferation of ER-positive breast cancer cells
    Xue, Jing
    Dai, Yunfeng
    Li, Guofeng
    Lang, Weiya
    Li, Penghui
    Liu, Yunlong
    Bao, Hongguang
    Zhao, Dalong
    Pan, Hongming
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 528 (04) : 740 - 745
  • [45] Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer:: Specific correlation with progesterone receptor
    Saji, S
    Omoto, Y
    Shimizu, C
    Warner, M
    Hayashi, Y
    Horiguchi, S
    Watanabe, T
    Hayashi, S
    Gustafsson, JÅ
    Toi, M
    CANCER RESEARCH, 2002, 62 (17) : 4849 - 4853
  • [46] In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer
    Bouchmaa, Najat
    Ben Mrid, Reda
    Bouargalne, Youssef
    Ajouaoi, Sana
    Cacciola, Francesco
    El Fatimy, Rachid
    Nhiri, Mohamed
    Zyad, Abdelmajid
    PLOS ONE, 2023, 18 (02):
  • [47] INDUCTION OF PROGESTERONE-RECEPTOR IN AN ESTROGEN, PROGESTERONE RECEPTOR-NEGATIVE BREAST-CANCER CELL-LINE
    DEVLEESCHOUWER, N
    OLEASERRANO, N
    LECLERCQ, G
    LEGROS, N
    HEUSON, JC
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 24 (01): : 365 - 368
  • [48] Different proliferation patterns in breast cancer:: AgNOR measurements in ER-negative and ER-positive tumor cells
    Günther, L
    Hufnagl, P
    Winzer, KJ
    Guski, H
    ANALYTICAL CELLULAR PATHOLOGY, 2000, 20 (04): : 155 - 162
  • [49] IMPACT OF OATP2B1 EXPRESSION ON CELL PROLIFERATION IN ER-POSITIVE BREAST CANCER
    Matsumoto, Jun
    Ariyoshi, Noritaka
    Sakakibara, Masahiro
    Nakanishi, Takeo
    Tamai, Ikumi
    Nagashima, Takeshi
    Ishii, Itsuko
    DRUG METABOLISM REVIEWS, 2014, 45 : 268 - 268
  • [50] Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer
    Nikoic-Vukosavljevic, D
    Kanjer, K
    Neskovic-Konstantinovic, Z
    Vukotic, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 196 - 200
12345